Literature DB >> 23264496

Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation.

Louise Sivertsson1, Irene Edebert, Margareta Porsmyr Palmertz, Magnus Ingelman-Sundberg, Etienne P A Neve.   

Abstract

We have previously shown that confluent growth of the human hepatoma cell line Huh7 substantially induces the CYP3A4 mRNA, protein, and activity levels. Here, the mechanisms behind were investigated, and a transcriptome analysis revealed significant up-regulation of liver-specific functions, whereas pathways related to proliferation and cell cycle were down-regulated in the confluent cells. Reporter analysis revealed that the CYP3A4 gene was transcriptionally activated during confluence in a process involving pregnane X receptor (PXR). PXR expression was increased, and PXR protein accumulated in the nuclei during confluent growth. The PXR ligand rifampicin further increased the expression of CYP3A4, and siRNA-mediated knock-down of PXR in confluent cells resulted in decreased CYP3A4 expression. Cyclin-dependent kinase 2 (CDK2), a known modulator of the cell cycle and a negative regulator of PXR, was more highly expressed in proliferating control cells. Trypsinization of the confluent cells and replating them subconfluent resulted in a decrease in CYP3A4 and PXR expression back to levels observed in subconfluent control cells, whereas the CDK2 levels increased. Knock-down of CDK2 in proliferating control cells increased the CYP3A4 and PXR protein levels. Moreover, the CDK inhibitor roscovitine stimulated the expression of CYP3A4. A phosphorylation-deficient mutation (S350A) in the PXR protein significantly induced the CYP3A4 transcription. In conclusion, the data strongly suggest that the increased CYP3A4 expression in confluent Huh7 cells is caused by the endogenous induction of PXR as a result of cell-cell contact inhibited proliferation and subsequent decreased CDK2 activities, indicating an endogenous, non-ligand-dependent regulation of PXR and CYP3A4, possibly of physiologic and pharmacological significance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264496     DOI: 10.1124/mol.112.082305

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

Review 1.  Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.

Authors:  Susumu Kodama; Masahiko Negishi
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

2.  3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression.

Authors:  Phillip L Lewis; Richard M Green; Ramille N Shah
Journal:  Acta Biomater       Date:  2018-01-06       Impact factor: 8.947

3.  CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism.

Authors:  Casey R Dorr; Rory P Remmel; Amutha Muthusamy; James Fisher; Branden S Moriarity; Kazuto Yasuda; Baolin Wu; Weihua Guan; Erin G Schuetz; William S Oetting; Pamala A Jacobson; Ajay K Israni
Journal:  Drug Metab Dispos       Date:  2017-05-22       Impact factor: 3.922

4.  Serine 350 of human pregnane X receptor is crucial for its heterodimerization with retinoid X receptor alpha and transactivation of target genes in vitro and in vivo.

Authors:  Yue-Ming Wang; Sergio C Chai; Wenwei Lin; Xiaojuan Chai; Ayesha Elias; Jing Wu; Su Sien Ong; Satyanarayana R Pondugula; Jordan A Beard; Erin G Schuetz; Su Zeng; Wen Xie; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2015-06-25       Impact factor: 5.858

5.  Generation of functional hepatocyte 3D discoids in an acoustofluidic bioreactor.

Authors:  Mogibelrahman M S Khedr; Walid Messaoudi; Umesh S Jonnalagadda; Ahmed M Abdelmotelb; Peter Glynne-Jones; Martyn Hill; Salim I Khakoo; Mohammed Abu Hilal
Journal:  Biomicrofluidics       Date:  2019-02-12       Impact factor: 2.800

Review 6.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

Review 7.  Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily.

Authors:  Tomas Smutny; Sridhar Mani; Petr Pavek
Journal:  Curr Drug Metab       Date:  2013-12       Impact factor: 3.731

8.  Protein expression and function of organic anion transporters in short-term and long-term cultures of Huh7 human hepatoma cells.

Authors:  Melina M Malinen; Katsuaki Ito; Hee Eun Kang; Paavo Honkakoski; Kim L R Brouwer
Journal:  Eur J Pharm Sci       Date:  2019-01-24       Impact factor: 4.384

Review 9.  Nuclear receptor phosphorylation in xenobiotic signal transduction.

Authors:  Masahiko Negishi; Kaoru Kobayashi; Tsutomu Sakuma; Tatsuya Sueyoshi
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

10.  Co-expression of drug metabolizing cytochrome P450 enzymes and estrogen receptor alpha (ESR1) in human liver: racial differences and the regulatory role of ESR1.

Authors:  Joseph M Collins; Danxin Wang
Journal:  Drug Metab Pers Ther       Date:  2021-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.